Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin - Concepedia

Concepedia

Publication | Open Access

Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin

DOI Full Paper Access

89

Citations

38

References

2013

Year

Rebecca A. Dumont, Maria‐Luisa Tamma, Friederike Braun, Sandra Borkowski, Jean Claude Reubi, Helmut R. Maëcke, Wolfgang Weber, Rosalba Mansi

Journal of Nuclear Medicine

Abstract

Radiotherapy using a (177)Lu-labeled GRPr antagonist alone or in combination with rapamycin was efficacious in inhibiting in vivo tumor growth and may be a promising strategy for treatment of prostate cancer.

References

	Year	Citations

Page 1